Gabapentin is used to treat nerve pain from shingles and to help control certain types of seizures. It's also commonly prescribed to help manage pain and other symptoms related to damaged nerves.[2] Neurontin is currently approved and in use across 100 indications[4].[1]
Neurontin is one of 1580 small molecule programs targeting Childhood Acute Lymphoblastic Leukemia. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
2828 competitors in Breast Cancer
Neurontin
Tecentriq
Adriamycin
Nolvadex
Prolia
Megace
DATROWAY
MS Contin
Zolymbus
Methylthioninium Chloride
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Dec 30, 1993
NEURONTIN
NDA NDA020235
Oct 9, 1998
NEURONTIN
NDA NDA020882
Mar 2, 2000
NEURONTIN
NDA NDA021129
Jan 28, 2011
GRALISE
NDA NDA022544
Sources
Details